THE DEAL, AT A GLANCE
From the announcementOllin Biosciences
01What happenedOllin Biosciences raised $330M Series B, announced 2026-06-24From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersOllin Biosciences' $330M Series B supports advancement of OLN324 into global Phase 3 development for DME and wet AMD, with studies expected to commence in the second…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Ollin Biosciences · Financing Record
Explore source-linked visual explanations for Ollin Biosciences. Unsupported claims are withheld while source review continues.
Record 6662 · Recorded date: 2026-06-24
Explore company records →